182 related articles for article (PubMed ID: 18257960)
1. Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease.
Palmer K; Bäckman L; Winblad B; Fratiglioni L
Int Psychogeriatr; 2008 Apr; 20(2):252-8. PubMed ID: 18257960
[TBL] [Abstract][Full Text] [Related]
2. Predictors of progression from mild cognitive impairment to Alzheimer disease.
Palmer K; Berger AK; Monastero R; Winblad B; Bäckman L; Fratiglioni L
Neurology; 2007 May; 68(19):1596-602. PubMed ID: 17485646
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
[TBL] [Abstract][Full Text] [Related]
4. Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study.
Ramakers IH; Visser PJ; Aalten P; Kester A; Jolles J; Verhey FR
Psychol Med; 2010 Jul; 40(7):1193-201. PubMed ID: 19903364
[TBL] [Abstract][Full Text] [Related]
5. [Neuropsychological impairment in the early Alzheimer's disease].
Traykov L; Rigaud AS; Cesaro P; Boller F
Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
[TBL] [Abstract][Full Text] [Related]
6. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease.
Palmer K; Bäckman L; Winblad B; Fratiglioni L
Am J Geriatr Psychiatry; 2008 Jul; 16(7):603-11. PubMed ID: 18591580
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
8. Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
Clément F; Belleville S; Gauthier S
J Int Neuropsychol Soc; 2008 Mar; 14(2):222-32. PubMed ID: 18282320
[TBL] [Abstract][Full Text] [Related]
9. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
[TBL] [Abstract][Full Text] [Related]
10. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.
Devanand DP; Michaels-Marston KS; Liu X; Pelton GH; Padilla M; Marder K; Bell K; Stern Y; Mayeux R
Am J Psychiatry; 2000 Sep; 157(9):1399-405. PubMed ID: 10964854
[TBL] [Abstract][Full Text] [Related]
11. A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis.
Jones S; Laukka EJ; Small BJ; Fratiglioni L; Bäckman L
Dement Geriatr Cogn Disord; 2004; 18(3-4):233-9. PubMed ID: 15286452
[TBL] [Abstract][Full Text] [Related]
12. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
[TBL] [Abstract][Full Text] [Related]
13. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
[TBL] [Abstract][Full Text] [Related]
14. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis.
Ingles JL; Boulton DC; Fisk JD; Rockwood K
Stroke; 2007 Apr; 38(4):1148-53. PubMed ID: 17322075
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
[TBL] [Abstract][Full Text] [Related]
16. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.
Palmer K; Di Iulio F; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Spalletta G
J Alzheimers Dis; 2010; 20(1):175-83. PubMed ID: 20164594
[TBL] [Abstract][Full Text] [Related]
20. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
